contadores web
Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article

Vol. 20 No. 3 (2018)

Reticulocyte hemoglobin and its importance in early diagnosis of iron deficiency anemia

DOI
https://doi.org/10.22267/rus.182003.133
Submitted
March 8, 2018
Published
2018-08-31

Abstract

Introduction: The reticulocyte hemoglobin content (CHr) is a parameter in automated hematological biometrics, which can provide information on the iron content. So it has been used as a marker of the bioavailability of iron in the erythropoiesis, it allows its detection at an early stage of iron deficiency anemia and other pathologies such as chronic inflammation, chronic kidney disease; in addition to monitoring therapy with erythropoietin and iron. Objective: To expose the applicability of CHr as a parameter in the early diagnosis of iron deficiency anemia, as well as its measurement and interpretation. Materials and methods: The review of scientific articles in English and Spanish was carried out in the PubMed, ScienceDirect, LILACS and Medline databases, using descriptors validated in Medical Subject Headings (MeSH), considering the publication period of 80% less than 5 years. Results: The importance, applicability, determination and interpretation of this parameter is described as an early specific biomarker in the blood in the diagnosis of iron deficiency before presenting morphological changes occurring during terminal erythroid differentiation. Conclusions: CHr is a very useful parameter in the early diagnosis of iron deficiency anemia and other pathologies such as functional deficiency, chronic inflammation states and chronic renal disease

References

  1. World Health Organization. The global prevalence of anaemia in 2011 who library cataloguing-in-publication data. the global prevalence of anaemia in (2015th ed.). Geneva: WHO; 2011. Disponible en: apps.who.int/iris/bitstream/10665/177094/1/9789241564960_eng.pdf
  2. Donato H, Cedola A, Rapetti MC, Buys MC, Gutiérrez M, Parias-Nucci R, Schvartzman G. Anemia ferropénica. Guía de diagnóstico y tratamiento. Arch Argent Pediatr. 2010;107(4):353-361. Disponible en: http://www.sap.org.ar/uploads/consensos/anemia-ferrop-eacutenica-gu-iacutea-de-diagn-oacutestico-y-tratamiento.pdf
  3. Urrechaga E, Borque L, Escanero JF. Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis. BioMed Research International, 2013;2013:603786. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600252/
  4. Karagülle M, Gündüz E, Sahin-Mutlu F, Olga-Akay M. Clinical significance of reticulocyte hemoglobin content in the diagnosis of iron deficiency anemia. Turkish Journal of Haematology. 2013;30(2):153-156. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878462/pdf/TJH-30-153.pdf
  5. Buttarello M. Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how?. International Journal of Laboratory Hematology. 2016;38(S1):123-132. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/ijlh.12500/full
  6. Cai J, Wu M, Ren J, Du Y, Long Z, Li G, Yang L. Evaluation of the Efficiency of the Reticulocyte Hemoglobin Content on Diagnosis for Iron Deficiency Anemia in Chinese Adults. Nutrients. 2017;9(5):1-9. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452180/pdf/nutrients-09-00450.pdf
  7. Urrechaga-Igartua E, Hoffmann J, Izquierdo-Álvarez S, Escanero JF. Reticulocyte hemoglobin content (MCHr) in the detection of iron deficiency. Journal of Trace Elements in Medicine and Biology. 2017;43:29-32. Disponible en: https://doi.org/10.1016/J.JTEMB.2016.11.001
  8. Hernández-Reyes L, Fundora-Sarraff T, Andrade-Ruiseco M. El conteo automático de reticulocitos: una herramienta de uso diagnóstico, clínico e investigativo Automated reticulocyte count: a tool for diagnostic, clinical and research use. 2015;31(4):362-371. Disponible en: http://scielo.sld.cu/pdf/hih/v31n4/hih04415.pdf
  9. Torrens M. Interpretación clínica del hemograma. Revista Clínica Las Condes. 2015;26(6):713-725. Disponible en: https://www.sciencedirect.com/science/article/pii/S0716864015001480
  10. Barragán-Ibañez G, Santoyo-Sánchez A, Ramos-Peñafiel CO. Iron deficiency anaemia. Revista Médica Del Hospital General de México. 2016;79(2):88-97. Disponible desde Internet en: http://linkinghub.elsevier.com/retrieve/pii/S0185106315000918
  11. Rodak-Bernadette F, George A, Fritsma EMK. Hematología Fundamentos y aplicaciones clínicas. España: Ed Panamericana; 2014.
  12. Gómez-Casal F. Hematología. España: prensas de la Universidad de Zaragoza; 2016.
  13. Moras M, Lefevre SD, Ostuni MA. From Erythroblasts to Mature Red Blood Cells: Organelle Clearance in Mammals. Front Physiol. 2017;8:1076.
  14. Iniesta I. Hematopoyesis. España: Ediciones Oblicuas; 2014.
  15. Saito H, Hayashi H. Transformation rate between ferritin and hemosiderin assayed by serum ferritin kinetics in patients with normal iron stores and iron overload. Nagoya Journal of Medical Science. 2015;77(4):571-583. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664589/pdf/2186-3326-77-0571.pdf
  16. Saito H. Metabolism of Iron Stores. Nagoya J Med Sci. 2014;76(3-4):235-254. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345694/
  17. Alvarez-Argüelles H, Raya-Sánchez JM, García-Hernández S, Martín-Santos T, Brito-Barroso ML, Martín-Herrera A, Hernández-Nieto L. Correlación entre los depósitos de hemosiderina en biopsias de médula ósea y marcadores séricos de hierro corporal: validación de un método semicuantitativo de evaluación de la tinción de Perls. Revista Española de Patología. 2012;45(4):218-223.
  18. Sociedad Argentina de Hematología. Guías de diagnóstico y tratamiento. Argentina: Sociedad Argentina de Hematología; 2017.
  19. Sermini CG, Acevedo MJ, Arredondo M. Biomarcadores del metabolismo y nutrición de hierro. Rev Peru Med Exp Salud Pública. 2017;34(4):690-8. doi: 10.17843/rpmesp.2017.344.3182
  20. Crudo C, Erramouspe B, Sueldo E, Arias M. Perls Iron Stain. Hematología. 2016;20(2):243-246. Disponible en: http://www.sah.org.ar/revista/numeros/14%20vol%2020%20N2%20%202016.pdf
  21. Manito N, et al. Documento de consenso de la Sociedad Española de Cardiología y la Sociedad Española de Medicina Interna sobre el diagnóstico y tratamiento del déficit de hierro en la insuficiencia cardíaca. Rev Clin Esp. 2016. Disponible en: http://dx.doi.org/10.1016/j.rce.2016.08.001
  22. Wolff F, Deleers M, Melot C, Gulbis B, Cotton F. Hepcidin-25: Measurement by LCMS/MS in serum and urine, reference ranges and urinary fractional excretion. Elsevier Inc. 2013;413:99-104.
  23. Cailliat MC, Fink NE. Algoritmos de laboratorio para el estudio del estado del hierro. Acta bioquím. clín. latinoam. [Internet]. 2013 ;47(3):507-22. [Citado 2018 Mar 23] Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-29572013000300005
  24. Büyükkaragöz B, Akgun NA, Bulus AD, Durmus-Aydogdu S, Bal C. ¿Puede usarse el receptor soluble de transferrina para diagnosticar anemia ferropénica y evaluar la respuesta al hierro en lactantes con desnutrición aguda moderada?. Arch. argent. pediatr. [Internet]. 2017;115(2):125-132. [Citado 2018 Mar 23] Disponible en:http://dx.doi.org/10.5546/aap.2017.125
  25. Eguchi A, Mochizuki T, Tsukada M, Kataoka K, Hamaguchi Y, Oguni S, et al. Clinical Study Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients. Int J Nephrol [Internet]. 2012;7:7. [Citado 2018 Enero 22]Disponible en: https://www.hindawi.com/journals/ijn/2012/239476
  26. Babaei M, Shafiei S, Bijani A, Heidari B, Hosseyni SR, Vakili-Sadeghi M. Ability of serum ferritin to diagnose iron deficiency anemia in an elderly cohort. Revista Brasileira de Hematologia E Hemoterapia. 2017;39(3):223-228. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568592/pdf/main.pdf
  27. Camaschella C, Pagani A. Advances in understanding iron metabolism and its crosstalk with erythropoiesis. Br J Haematol. 2018;182(4):1-14. doi: 10.1111/bjh.15403
  28. Ward DM, Kaplan J. Ferroportin-mediated iron transport: Expression and regulation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2012;1823(9):1426-1433. Disponible desde Internet en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718258/pdf/nihms367717.pdf
  29. Parodi E, Giraudo MT, Ricceri F, Aurucci ML, Mazzone R, Ramenghi U. Absolute Reticulocyte Count and Reticulocyte Hemoglobin Content as Predictors of Early Response to Exclusive Oral Iron in Children with Iron Deficiency Anemia. Anemia. 2016;2016:1-6. Disponible en:https://www.hindawi.com/journals/anemia/2016/7345835/
  30. Al-Ghananim RT, Nalbant D, Schmidt RL, Cress GA, Zimmerman MB, Widness JA. Reticulocyte Hemoglobin Content During the First Month of Life in Critically Ill Very Low Birth Weight Neonates Differs From Term Infants, Children, and Adults. Journal of Clinical Laboratory Analysis. 2016;30(4):326-334. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644110/pdf/nihms680716.pdf
  31. Peerschke EIB, Pessin MS, Maslak P. (2014). Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer. American Journal of Clinical Pathology. 2014;142(4):506-512. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962332/pdf/nihms802884.pdf
  32. Crudo C, Erramouspe B, Sueldo E, Arias M. Tinción de hierro medular. Coloración de Perls Perls Iron Stain. Hematología. 2016;20(2):243-246. Disponible en: http://www.sah.org.ar/revista/numeros/14%20vol%2020%20N2%20%202016.pdf
  33. Daru J, Colman K, Stanworth SJ, De La Salle B, Wood EM, Pasricha SR. (2017). Serum ferritin as an indicator of iron status: what do we need to know? The American Journal of Clinical Nutrition. 2017;106(Suppl 6):1634S-1639S.
  34. Lichtman, A. (2014). Manual de Hematología. 8 ed. España: McGraw-Hill; 2014.
  35. Forrellat-Barrios M, Fernández-Delgado N, Hernández-Ramírez P. Regulación de la hepcidina y homeostasis del hierro: avances y perspectivas. Revista Cubana de Hematología, Inmunología Y Hemoterapia. 2012;28(4):347-356. Disponible en: http://www.medigraphic.com/pdfs/revcubheminmhem/rch-2012/rch124d.pdf
  36. Piero A, Courtois V, Bastida S, Sánchez-Muniz FJ, Vaquero MP. Deficiencia y sobrecarga de hierro; implicaciones en el estado oxidativo y la salud cardiovascular. Nutrición Hospitalaria. 2010;25(3):350-365. Disponible desde Internet en: http://www.redalyc.org/pdf/3092/309226757003.pdf
  37. Pfeiffer CM, Looker AC. Laboratory methodologies for indicators of iron status: strengths, limitations, and analytical challenges. The American Journal of Clinical Nutrition. 2017;106(Suppl 6):1606S-1614S.
  38. Lynch S, Pfeiffer CM, Georgieff MK, Brittenham G, Fairweather-Tait S, Hurrell RF, et al. Biomarkers of Nutrition for Development (BOND)-Iron Review. J Nutr. 148(suppl_1):1001S-1067S.
  39. Northrop-Clewes CA, Thurnham DI. Biomarkers for the differentiation of anemia and their clinical usefulness. Journal of Blood Medicine. 2013;4:11-22. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610441/pdf/jbm-4-011.pdf
  40. Quintana-Guzmán EM, Salas-Chaves MdelP. Receptores solubles de transferrina como mejor indicador bioquímico para definir deficiencia de hierro. Acta Bioquímica Clínica Latinoamericana. 2010;44(3):311-316. Disponibleen:http://www.scielo.org.ar/pdf/abcl/v44n3/v44n3a02.pdf
  41. Hoon-Yoon S, Sup-Kim D, Taek-Yu S, Ron-Shin S, Young-Choi D. The usefulness of soluble transferrin receptor in the diagnosis and treatment of iron deficiency anemia in children. Korean J Pediatr. 2015;58(1):15-19. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342776/pdf/kjped-58-15.pdf .
  42. Means RT. Pathophysiology in Medicine: Hepcidin and iron regulation in health and disease. Am J Med Sci. 2013;345(1):57-60. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430792/
  43. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2013;117(17):4425-4433. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099567/
  44. Le Petitcorps H, Monti A, Pautas É. Iron deficiency in elderly patients: use of biomarkers. Ann Biol Clin (Paris). 2015;73(6):639-42.
  45. Forrellat-Barrios M. Diagnóstico de la deficiencia de hierro: aspectos esenciales. Revista Cubana de Hematología, Inmunología y Hemoterapia. 2017;33(2):1-9.
  46. Kemper AR, Fan T, Grossman DC, Phipps MG. Gaps in evidence regarding iron deficiency anemia in pregnant women and young children: summary of US Preventive Services Task Force recommendations. The American journal of clinical nutrition. 2017;106(Supplement 6):1555S-8S.
  47. Schapkaitz E. Stability of New Erythrocyte and Reticulocyte Parameters in Testing for Anemia on the Sysmex XN 9000. Laboratory Medicine. 2018;10(4):356-360.
  48. Buttarello M, Rauli A, Mezzapelle G. Reticulocyte count and extended reticulocyte parameters by Mindray BC-6800: Reference intervals and comparison with Sysmex XE-5000. International Journal of Laboratory Hematology. 2017;39(6):596-603.
  49. Mast AE, Blinder MA, Dietzen DJ. Reticulocyte hemoglobin content. American Journal of Hematology. 2008;83(4):307-310.
  50. Becker K. Ana. Interpretación del hemograma. Rev. chil. pediatr. [Internet]. 2001;72(5):460-465. [Citado 2018 Mayo 07]; Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0370-41062001000500012
  51. Torrens Mónica. Interpretación clínica del hemograma. Rev. Med. Clin. Condes [Internet]. 2015;26(6)713-725. [citado 2018 Mayo 07]; Disponible en: https://www.researchgate.net/publication/290009900_INTERPRETACION_CLINICA_DEL_HEMOGRAMA
  52. Campuzano G. Interpretación del hemograma automatizado: claves para una mejor utilización de la prueba. Med. lab [Internet]. 2013;19(1,2):11-68. [citado 2018 Mayo 07]; Disponible en: http://www.edimeco.com/component/zoo/item/interpretacion-del-hemograma-automatizado-claves-para-una-mejor-utilizacion-de-la-prueba
  53. Brugnara C, Laufer MR, Friedman AJ, Bridges K, Platt O. Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood. 1994;83(10):3100-1.
  54. Fishbane S, Galgano C, Langley-Jr RC, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney international. 1997;52(1):217-22.
  55. Brugnara C, Jo-Hipp M, Irving PJ, Lathrop H, Lee PA, Minchello EM, Winkelman J. Automated reticulocyte counting and measurement of reticulocyte cellular indices: evaluation of the Miles H* 3 blood analyzer. American Journal of Clinical Pathology. 1994;102(5):623-32.
  56. Ledesma-Herrera AM, Pedraza-García AL. Hemoglobina reticulocitaria en donantes de sangre. [Trabajo de grado]. Bogotá: Universidad Javeriana; 2010.
  57. Eguchi A, Mochizuki T, Tsukada M, Kataoka K, Hamaguchi Y, Oguni S, Tsuchiya K. Clinical Study Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients. International Journal of Nephrology. 2012;7:7. Disponible en: https://www.hindawi.com/journals/ijn/2012/239476
  58. Baart AM, Balvers MGJ, Hopman MTE, Eijsvogels TMH, Klein Gunnewiek JMT, van Kampen CA. Reticulocyte hemoglobin content in a large sample of the general Dutch population and its relation to conventional iron status parameters. Clin Chim Acta. 2018;8(483):20-4.
  59. Capone D, Cataldi M, Viniguerra M, Mosca T, Barreta S, Ragosta A, Sorretino A. Reticulocyte Hemoglobin Content Helps Avoid Iron Overload in Hemodialysis Patients: A Retrospective Observational Study. In Vivo. 2017;31(4):709-712. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566927/pdf/in_vivo-31-709.pdf
  60. Campuzano G. Hemoglobina Reticulocitaria: Un nuevo parámetro del Hemograma de gran valor en el diagnóstico y manejo de la eritropoyesis deficiente en hierro. Medicina Y Laboratorio. 2015;21(1-2):11-12.
  61. Wolf-Grotto HZ. Platelet and reticulocyte new parameters: why and how to use them? Revista Brasileira de Hematologia E Hemoterapia. 20165;38(4):283-284. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119670/pdf/main.pdf
  62. Láser L, Hernández-Reyes H. Avances y aplicación clínica de la citometría hemática automatizada. Revista Cubana Hematología Inmunología Y Hemoterapia. 2013;2929(11):24-3924. Disponible en: http://scielo.sld.cu/pdf/hih/v29n1/hih04113.pdf
  63. Canalejo K, Aixalá M, Casella A, Capanera P, Medina J, Jelen A. Evaluación de la fracción de reticulocitos inmaduros como parámetro de ferropenia en el embarazo. Acta Bioquím Clín Latinoam. 2011;45(1):81-85. Disponible en: http://www.scielo.org.ar/pdf/abcl/v45n1/v45n1a04.pdf
  64. Camargo-Morkis IV, Granero-Farias M, Scotti L. Determination of reference ranges for immature platelet and reticulocyte fractions and reticulocyte hemoglobin equivalent. Revista Brasileira de Hematologia E Hemoterapia. 2016;38(4):310-313. Disponible desde Internet en: https://www.sciencedirect.com/science/article/pii/S151684841630072X
  65. Barbosa-Torino AB, Pererira-Gilberti AdeF, da Costa E, Freire de Lima GA, Zerlotti H. Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease. Revista Brasileira de Hematologia E Hemoterapia. 2015;3(72):77-81. Disponible desde Internet en: http://www.scielo.br/pdf/rbhh/v37n2/1516-8484-rbhh-37-02-00077.pdf
  66. Stein J, Dignass AU, Sachsenhausen K. Management of iron deficiency anemia in inflammatory bowel disease - a practical approach. Annals of Gastroenterology Ann Gastroenterol. 2013;26(262):104-113. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959949/pdf/AnnGastroenterol-26-104.pdf
  67. Nairz M, Theurl I, Wolf D, Weiss G, Nairz M, Theurl I, Wolf D. Main topic Iron deficiency or anemia of inflammation? Differential diagnosis and mechanisms of anemia of inflammation Eisenmangel oder Entzündungsanämie? Wiener Medizinische Wochenschrift. 2016;166:411-423. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065583/pdf/10354_2016_Article_505.pdf
  68. Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, Bhandari S. Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease. BMC Nephrology. 2017;18:345. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709852/pdf/12882_2017_Article_688.pdf
  69. Wang Y, Lu X, He J, Zhao W. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease. Stem Cell Research & Therapy. 2012;6(1):100. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469245/
  70. Davis-Ajami ML, Wu J, Downton K, Ludeman E, Noxon V. Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility. Biologics: Targets and Therapy. 2014;8:155-167. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999275/pdf/btt-8-155.pdf
  71. Wang L, Lijun Di, Noguchi CT. Erythropoietin, a Novel Versatile Player Regulating Energy Metabolism beyond the Erythroid System. Int. J. Biol. Sci. 2014;10(8):921-939. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147225/pdf/ijbsv10p0921.pdf
  72. Mairbäurl H, Bogdanova A, Lombardi G. Red blood cells in sports: effects of exercise and training on oxygen supply by red blood cells. Frontiers in Physiology. Front Physiol. 2013;4:332. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824146/pdf/fphys-04-00332.pdf
  73. Sudmann ÅA, Piehler A, Urdal P, Shild Å, Sudmann A. (2012). Reticulocyte hemoglobin equivalent to detect thalassemia and thalassemic hemoglobin variants. International Journal of Laboratory Hematology 2012;34:605-613. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533779/pdf/ijlh0034-0605.pdf
  74. Buoro S, Mecca T, Seghezzi M, Manenti B, Cerutti L, Dominoni P, Lippi G. Assessment of blood sample stability for complete blood count using the Sysmex XN-9000 and Mindray BC-6800 analyzers. Revista Brasileira de Hematologia E Hemoterapia. 2016;38(3):225-239. Disponible desde Internet en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997904/pdf/main.pdf
  75. Ibáñez-Alcalde MM, Vázquez-López MÁ, Ruíz-Sánchez AM, Lendínez-Molinos FJ, Galera-Martínez R, Bonillo-Perales A, et al. Reference Values of Reticulocyte Hemoglobin Content in Healthy Adolescents. J Pediatr Hematol Oncol. 2018;40(4):298-303.

Downloads

Most read articles by the same author(s)